RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/a-2591-9608
Single-Stage Quadruple Valve Replacement with Mechanical and Bioprosthetic Valves: An 8-Year Follow-up Study from India
Funding None.
Abstract
Background
Congenital heart disease, repaired or unrepaired, requires lifelong follow-up. Carcinoid disease, rheumatic heart disease, and infective endocarditis can damage all four cardiac valves. Multiple valve replacement has a poor outcome.
Case Description
A 23-year-old male underwent single-stage quadruple valve (mechanical [mitral and aortic] and bioprosthetic [tricuspid and pulmonary]) replacement due to rheumatic carditis and surgical complications. Over 8 years of follow-up, he is asymptomatic, has no prosthetic valve-related complications, and has improved cardiac function.
Conclusion
Single-stage quadruple valve replacement with mechanical and bioprosthetic valves has a good long-term outcome. To the best of our knowledge, this is the longest follow-up study from India.
Note
This study was presented at CSI Frankfurt on June 21, 2024, as a poster presentation.
Publikationsverlauf
Eingereicht: 22. Februar 2025
Angenommen: 07. April 2025
Accepted Manuscript online:
22. April 2025
Artikel online veröffentlicht:
26. Mai 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Brown Jr PS, Roberts CS, McIntosh CL, Swain JA, Clark RE. Late results after triple-valve replacement with various substitute valves. Ann Thorac Surg 1993; 55 (02) 502-508
- 2 Alsoufi B, Rao V, Borger MA. et al. Short- and long-term results of triple valve surgery in the modern era. Ann Thorac Surg 2006; 81 (06) 2172-2177 , discussion 2177–2178
- 3 Adembesa I, Myburgh A, Swanevelder J. Quadruple valve replacement in a patient with severe rheumatic heart disease. Echo Res Pract 2018; 5 (02) K47-K51
- 4 Hossack KF, Hopeman AR, Sutherland III EW. Long-term follow-up of a patient with quadruple valve replacement. Tex Heart Inst J 1987; 14 (03) 315-317
- 5 Oeser C, Andreas M, Habertheuer A, Kocher A. Quadruple valve replacement and bypass surgery 23 years after the Ross operation. Interact Cardiovasc Thorac Surg 2015; 21 (01) 132-134
- 6 Cao Y, Gu C, Sun G, Yu S, Wang H, Yi D. Quadruple valve replacement with mechanical valves: an 11-year follow-up study. Heart Surg Forum 2012; 15 (03) E145-E149
- 7 Seeburger J, Groesdonk H, Borger MA. et al. Quadruple valve replacement for acute endocarditis. J Thorac Cardiovasc Surg 2009; 137 (06) 1564-1565
- 8 Wen Y, Liu X, Zhao Y, Liu J, Miao Q. Quadruple valve replacement for patient with infective endocarditis 16 years after Fallot's Tetralogy Repair procedure: A case report. Heliyon 2023; 10 (01) e23351
- 9 Mujtaba SS, Clark S. Quadruple valve replacement for carcinoid heart disease. Braz J Cardiovasc Surg 2018; 33 (04) 398-403
- 10 Albåge A, Alström U, Forsblad J, Welin S. Quadruple bioprosthetic valve replacement in a patient with severe carcinoid heart disease. JACC Case Rep 2020; 2 (02) 271-276
- 11 Otto CM, Nishimura RA, Bonow RO. et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143 (05) e72-e227 . Accessed April 28, 2025 at: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000923
- 12 Vahanian A, Beyersdorf F, Praz F. et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 2022; 75 (06) 524